Skip to main content

Psychological Support for the Breast Cancer Patient

  • Chapter
Management of Breast Diseases
  • 1928 Accesses

Abstract

A woman confronted by the diagnosis of breast cancer faces the challenges of a life-threatening illness. The seriousness of the diagnosis, the nature of treatment, and the natural history of illness defines the challenge to coping. Each woman looks to her physician first for clarification of the medical treatment. Since treatment often requires breast surgery, a combination of chemotherapy and radiation, and antiestrogen treatment that hastens menopause, the psychological effects are different for premenopausal women married with children, women concerned about their physical attractiveness or who want to preserve fertility, and women concerned about the effect on their partners. The diagnosis has one meaning for a woman with a family history of breast cancer who suffered in her adolescence as her mother died of breast cancer, and another if she is married to a man who lost his mother to breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Barton MB, Morley DS, Moore S, Allen JD, Kleinman KP, Emmons KM, Fletcher SW (2004) Decreasing women’s anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst. 96:529–38

    Article  PubMed  Google Scholar 

  2. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA (1999) Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 353:1127–31

    Article  CAS  PubMed  Google Scholar 

  3. Jones SE, Cantrell J, Vukelja S, Pippen J, O’Shaughnessy J et al (2007) Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a tamoxifen exemestane adjuvant multi-center trial substudy. J Clin Oncol. 25:4765–71

    Article  CAS  PubMed  Google Scholar 

  4. Fallowfield L, Cella D, Cuzick J, et al (2004) Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in combination (ATAC) adjuvant breat trial. J Clin Oncol. 22:4261–71

    Article  CAS  PubMed  Google Scholar 

  5. Thomas R, Williams M, Marshall C, Walker L (2008) Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women. Brit J Cancer. 98:1494–9

    Article  CAS  PubMed  Google Scholar 

  6. Waterhouse DM, Calzone KA, Mele C, Brenner DE (1993) Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 11:1189–97

    CAS  PubMed  Google Scholar 

  7. Partridge AH, Wang PS, Winer EP, et al (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 21:602–6

    Article  CAS  PubMed  Google Scholar 

  8. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA (2006) Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat. 99:215–20

    Article  PubMed  Google Scholar 

  9. Kahn KL, Schneider EC, Malin J, Adams JL, Epstein AM (2007) Patient-centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care. 45:431–9

    Article  PubMed  Google Scholar 

  10. Patridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early stage breast cancer. J Clin Oncol. 26:556–62

    Article  CAS  Google Scholar 

  11. Grunberg SM (2007) Antienmetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol. 18:233–40

    Article  CAS  PubMed  Google Scholar 

  12. Buysse DJ, Reynolds DC III, Hauri PJ et al (1994) Diagnostic concordance for DSM IV sleep disorders: a report from the APA/NIMH DSV-IV field trial. Am J Psychiatry. 151:1351–60

    CAS  PubMed  Google Scholar 

  13. Benca RM, Obermeyer WH, Thisted RA, et al (1992) Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 49:651–68

    CAS  PubMed  Google Scholar 

  14. Weilburg JB, Stakes JW, Roth T. (2008) Sleep Disorders. In: Stern TA, Rosenbaum JF, Fava M, Biederman J. Rauch SL, editors. Comprehensive Clinical Psychiatry. Mosby Elsevier; p. 285–99

    Google Scholar 

  15. Carpenter JS, Andrykowski MA, Cordova M, Cunningham L, Studts J, McGrath P, Kenady D, Sloan D, Munn R (1998) Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer. 82:1682–91

    Article  CAS  PubMed  Google Scholar 

  16. Kronenberg F (1994) Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol. 29: 319–36

    Article  CAS  PubMed  Google Scholar 

  17. Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, Lanier M, Smard S, Morin CM (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Sympt Manage. 27:513–22

    Article  Google Scholar 

  18. Stearns V, Beebe KL, Lyengar M, Dube E (2003) Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. AMA. 289:2827–34

    Article  CAS  Google Scholar 

  19. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA et al (2002) Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 20:1578–83

    Article  CAS  PubMed  Google Scholar 

  20. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet. 356:2059–63

    Article  CAS  PubMed  Google Scholar 

  21. Pandya KJ, Morrow GR, Roscoe JA, Zhao H et al (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet. 366:818–24

    Article  CAS  PubMed  Google Scholar 

  22. Bardwell WA, Pronfant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, Rock CL, Pierce JP (2008) The relative importance of specific risk factors for insomnia in women treated for early stage breast cancer. Psychooncology. 17:9–18

    Article  PubMed  Google Scholar 

  23. Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer. 94:828–34

    Article  CAS  PubMed  Google Scholar 

  24. Joffee H, Hall JE, Gruber S et al (2006) Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in premenopausal and recently postmenopausal women. Menopause. 12:411–22

    Article  Google Scholar 

  25. Silverman DH, Dy CJ, Castellon S, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA (2007) Altered frontocortical cerebellar and basal ganglia activity in adjuvant treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat. 103:303–11

    Article  CAS  PubMed  Google Scholar 

  26. Schmidt P, Nieman LK, Danaceau MA, Adamas LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 338:209–16

    Article  CAS  PubMed  Google Scholar 

  27. Cohen LS, Soares CN, Otto MW, Vitonis AF, Harlow BL (2006) Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 63:385–90

    Article  PubMed  Google Scholar 

  28. Schmidt PJ, Haq N, Rubinow MD, David R (2004) A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 161:2238–44

    Article  PubMed  Google Scholar 

  29. Soares CN, Helga A, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS (2006) Escitalopram versus ethyinyl estradiol and norethindrone acetate for symptomatic peri-and postmenopausal women: impact on depression, vasomotory symptoms, sleep, and quality of life. Menopause. 13:780–6

    Article  PubMed  Google Scholar 

  30. Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 58:529–34

    Article  CAS  PubMed  Google Scholar 

  31. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen P (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 23:6613–22

    Article  PubMed  Google Scholar 

  32. Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobesen PB. (2007) From: Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol. 26:464–72

    Article  PubMed  Google Scholar 

  33. Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 13:589–98

    Article  CAS  PubMed  Google Scholar 

  34. Servaes P, Verhagen CA, Bleijenberg G (2002) Relations between fatigue, neuropsychological functioning and physical activity after treatment for breast carcinoma. Cancer. 95:2017–26

    Article  PubMed  Google Scholar 

  35. Servaes PM, Gielissen MF, Verhagen S, Bleijenberg G (2007) The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psycho Onology. 16:787–95

    Article  CAS  Google Scholar 

  36. Bower JE, Ganz PA. Desmond KA, Bernards C, Rowland JH, Meyerowitz BE, Belin TR (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 106:751–8

    Article  PubMed  Google Scholar 

  37. Sharpe M, Hawton K, Simpkin S, Surawy C, Hackman A, Klimes I, Peto T, Warrel D, Seagroatt V (1996) Cognitive behaviour therapy for chronic fatigue syndrome: a randomized controlled trial. Br Med J. 312:22–6

    CAS  Google Scholar 

  38. Gielissen MF, Verhagn S, Witjes F, Bleijenberg G (2006) Effects of cognitive behavioral therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavioral therapy: a randomized controlled trial. J clin Oncol. 42:4882–7

    Article  Google Scholar 

  39. Barsevick AM, Dudley W, Beck S et al (2000) A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 100:1302–10

    Article  Google Scholar 

  40. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M. McGregor BA, Gralow J (2008) Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 30:112–26

    Article  PubMed  Google Scholar 

  41. Hjerl K, Andersen EW, Keiding N, Mortensen PB, Jorgensen T (2002) Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: a nation-wide cohort study in Denmark. Acta Psychiatrica Scandinavica. 105:258–64

    Article  CAS  PubMed  Google Scholar 

  42. Yousaf U, Christensen M-LM, Engholm G, Storm HH (2005) Suicides among Danish cancer patients 1971–1999. Br J Cancer. 92:995–1000

    Article  CAS  PubMed  Google Scholar 

  43. Schairer C, Brown LM, Chen BE, Howard R, Lynch CF et al (2006) Suicide after breast cancer: an international population-based study of 723810 women. J Natl Cancer Inst. 98:1416–9

    Article  PubMed  Google Scholar 

  44. Gonzalez-Perez A, Rodriquez LAG (2005) Breast cancer risk among users of antidepressant medications. Epidemiology. 16:101–5

    Article  PubMed  Google Scholar 

  45. Haque R, Enger SM, Chen W, Petitti DB (2004) Breast cancer risk in a large cohort of female antidepressant medication users. Cancer Lett. 221:61–5

    Article  CAS  Google Scholar 

  46. Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH et al (2005) CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst. 97:30–9

    Article  CAS  PubMed  Google Scholar 

  47. Lim HS, Lee HJ, Lee KS, Lee ES, Jang IJ, Ro J (2007) Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol. 25:3837–45

    Article  CAS  PubMed  Google Scholar 

  48. Goetz MP, Knox SK, Suman VJ, Safgren SL, Ames MM, Visscher DW et al (2007) The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 101:1213–21

    Article  CAS  Google Scholar 

  49. Ratliff B, Dietze EC, Bean GR, Moore C, Wanto S, Seewaldt VL (2004) Correspondence: Re: active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst. 96:883

    CAS  PubMed  Google Scholar 

  50. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ et al (2000) A comparison of nefazadone, the cognitive behavioral—analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 342:1462–70

    Article  CAS  PubMed  Google Scholar 

  51. Fawzy FI, Fawzy NW, Arndt LA et al (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry. 52:100–13

    CAS  PubMed  Google Scholar 

  52. Leubbert K, Dahme B, Hasenbring M (2001) The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytic review. Psycho Oncol. 10:490–502

    Article  Google Scholar 

  53. Spiegel D, Butler LD, Giese-Davis J, Koopman C, Miller E et al (2007) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. Cancer. 110:1130–8

    Article  PubMed  Google Scholar 

  54. Kissane DW, Li Y (2008) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized controlled trial. Cancer. 112:443–4

    Article  PubMed  Google Scholar 

  55. Kissane D, Grabsch B, Clarke DM et al (2007) Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology. 16:277–86

    Article  PubMed  Google Scholar 

  56. Classen PJ, Butler LD, Koopman C et al (2001) Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trail. Arch Gen Psychiatry. 58:494–501

    Article  CAS  PubMed  Google Scholar 

  57. Goodwin PJ, Leszcz M, Ennis M et al (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med/345:1719–26

    Article  CAS  PubMed  Google Scholar 

  58. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C (2007) Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry. 64:1368–76

    Article  PubMed  Google Scholar 

  59. Greenberg DB (2004) Barriers to the treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 32:127–35

    Article  PubMed  Google Scholar 

  60. Kessler RC, Berglund P, Bemler O, Jin R, Koretz D, Merkangas KR et al (2003) The epidemiology of major depressive disorder. JAMA. 289:3095–105

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Greenberg, D. (2010). Psychological Support for the Breast Cancer Patient. In: Jatoi, I., Kaufmann, M. (eds) Management of Breast Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69743-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69743-5_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69742-8

  • Online ISBN: 978-3-540-69743-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics